Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 8Breast 8Thoracic 3Gynecologic 2Sarcoma 1Other 1Head & Neck 1CNS 1

Conditions

Sarcoma 211Bone Neoplasms 58Breast Neoplasms 40Neoplasms 39Osteosarcoma 37Lymphoma 34Precursor Cell Lymphoblastic Leukemia-Lymphoma 31Gastrointestinal Stromal Tumors 31Dendritic Cell Sarcoma, Interdigitating 31Hodgkin Disease 29Lymphoma, Non-Hodgkin 27Leukemia 27Burkitt Lymphoma 25Melanoma 24Brain Neoplasms 24Multiple Myeloma 23Leukemia, Myeloid, Acute 23Sarcoma, Ewing 22Recurrence 21Lymphoma, Mantle-Cell 21Lymphoma, Large B-Cell, Diffuse 21Glioblastoma 21Neuroblastoma 20Lymphoma, Follicular 20Leukemia, Lymphocytic, Chronic, B-Cell 20Lymphoma, Large-Cell, Immunoblastic 18Gliosarcoma 18Sarcoma, Kaposi 17Prostatic Neoplasms 17Pancreatic Neoplasms 17

Interventions

regorafenib 1Standard of Care 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Patient Compliance × Sarcoma × Clear all
NCT04055220 2026-02-17

REGOSTA

Centre Leon Berard

Phase NA Recruiting
168 enrolled
Sarcoma

Pathologic Complete Response, Bone Neoplasms, Chondrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Patient Compliance, Sarcoma, Ewing, Osteosarcoma, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡